www bmy88 net
A pair of teams with minimal rest will face off in Nassau, Bahamas, on Sunday when No. 22 St. John takes on Georgia. St. John's (5-1), which will play its third game in four days, began the stretch in the Bahamas Championship on Thursday, dropping a heartbreaker to No. 13 Baylor. The Red Storm led by 18 in the first half before Baylor forced overtime. From there, St. John's rallied from five down with 1:47 left to send the game to a second overtime, where it saw Baylor knock down a pair of 3-pointers in the final seven seconds -- including Jeremy Roach's buzzer-beater -- to knock off the Red Storm 99-98. In the third-place game on Friday, St. John's breezed past Virginia 80-55. RJ Luis Jr. led the way with 18 points and four steals, followed by Kadary Richmond's 12 points, as the Red Storm took a one-point lead with 15:21 left in the first half and didn't trail again. "I'm really impressed with our guys, coming off a double-overtime, extremely emotional loss," St. John's head coach Rick Pitino said. "To respond that way was extremely impressive, both offensively and defensively." Pitino, in his second year with the Red Storm, was moved by something off the court on Friday, involving captain Zuby Ejiofor, who chipped in eight points, nine boards, two steals and two blocks. Ejiofor was serenaded by St. John's fans during the win, following his two missed free throws at the end of double overtime against Baylor. "When you've only been in a job for a year, you search for things you love about a place," Pitino said. "Tonight I found out what I love about St. John's. Our fans chanted Zuby's name the whole game, which doesn't happen anywhere else in America. I was really impressed with our fans and I thank them for making Zuby feel good, because he gives you all the energy." Luis leads the Red Storm with 17.3 points per game, followed by Ejiofor (10.7), Aaron Scott (10.5), Deivon Smith (10.3) and Richmond (10.2). Georgia enters Sunday's matchup looking to rebound from its first loss after falling to No. 15 Marquette 80-69 on Saturday. Georgia (5-1) battled back from a 15-point, second-half deficit, but was held to just three points over the final 4:57 in Saturday's loss. Blue Cain led the Bulldogs with a season-high 17 points, including five 3-pointers. "It's a process. It's a journey with this team," Bulldogs head coach Mike White said. "It's about continuing to make strides, continuing to protect our culture. ... At the end of the day, wins and losses are going to take care of themselves. We just have to embrace the process and enjoy it." Five-star freshman recruit Asa Newell was held to a season-low nine points but leads the team with 15.5 points per game. Silas Demary Jr. is second with 13.8. --Field Level MediaTribune News Network DOHA: Qatar Airways Group Chief Executive Officer, Eng Badr Mohammed Al Meer, took part in this year’s Doha Forum, highlighting the airline’s commitment to sustainable growth, its strategic partnerships and focus on innovation with CNN anchor and correspondent, Julia Chatterley. The 22nd edition of the Doha Forum was held under the patronage of His Highness the Amir Sheikh Tamim bin Hamad Al Thani. The Forum welcomed world leaders, policy-makers, and experts to discuss innovative solutions and action-oriented recommendations for globally critical challenges, including security and technological advancements. The discussion with Eng Al Meer explored the impact of transformative investments, the navigation of complex geopolitical landscapes and seizing opportunities in emerging markets. Eng Al Meer shed light on one of his top priorities, Qatar Airways 2.0, which is focused on employee well-being and retention. He also discussed strategic partnerships from Africa to Australia, and the honour of being awarded the World’s Best Airline by Skytrax in 2024 for the eighth time. Eng Al Meer, said: "I was proud to represent Qatar Airways at this year’s Doha Forum." "Our increasingly connected world has introduced unique challenges, but has also unearthed new opportunities for cross-cultural understanding, much to the benefit of the aviation industry. Qatar Airways has strong and strategic diplomatic ties across the world and is a key player on the global stage. The demand for our services has remained high during both peak and low travel seasons." He continued: "With our partnerships in the emerging markets in Africa, the Americas, and India, we have built on our strengths of agility and commitment to sustainable growth to prove time and time again that Qatar Airways remains resilient, nimble, and responsive to change. These qualities are essential for growth in a multi-lateral environment." "Owing to our new era of Qatar Airways 2.0, dedication to our workforce, and growing investments and partnerships, our airline serves as the optimal case study for thriving businesses in rapidly evolving landscapes." Delivering a record profit of $1.7 billion in the previous financial year, Qatar Airways continues to invest in the latest technologies, most recently as the first global airline to introduce Starlink Wi-Fi across its fleet. The airline also acquired a 25 per cent stake in Southern Africa’s regional carrier, Airlink, and has been granted interim authorisation by the Australian Competition and Consumer Commission to engage with Virgin Australia in co-operative conduct under an integrated alliance, following Qatar Airways Group’s announcement in October that it intends to acquire a minority 25 per cent equity stake in Virgin Australia from Bain Capital (subject to FIRB approval), as part of its dedication to global connectivity. Copy 08/12/2024 10
I like Martha Stewart. Always have. Two recent documentaries, "Martha" on Netflix and the CNN series "The Many Lives of Martha Stewart," follow the Greek drama that make Stewart a cultural fascination to this day. They recount the jihad against this visionary who came under attack for being a woman with fierce ambition. Admittedly, Stewart's hard-edged perfectionism and nuclear-powered drive had created some tension with her product, the "soft" home arts of cooking, flower arranging and chair reupholstering. But did she have to be destroyed? Sure, Stewart engaged in some insider trading that may have seemed nothing more than an innocent stock tip. She shouldn't have lied about it to the FBI. But did journalist Dominick Dunne have to call her the "Goddess of Greed" over a transaction that saved the creator of a billion-dollar business only $45,673? It sure didn't merit five months in prison. In 1987, the cultural hyenas jumped on her for signing a $5 million contract with Kmart. Stewart was allegedly "selling out" the domestic lifestyle she had cultivated, moving away from authenticity toward mass production and profit. Heaven forfend. The year before, The Disney Co.'s CEO walked off with a $90 million severance check after 14 months of undistinguished performance. She was tenacious. So what? Male executives wore that badge proudly. This woman built a business empire based on creating artistic cheese trays and making wreaths from dry leaves. Try that, Elon Musk. Some of her trouble came in the sub-message that our home lives had turned slovenly because Americans had stopped caring about family dinners and dust balls under the sofa. Some translated that not as a call to do better but as an indictment. But Stewart had no army. Those who accused her of creating unrealistic expectations for women juggling work and family should have been asked: Whose expectations? One could simply enjoy watching her on TV or reading her magazine, Martha Stewart Living. Her projects were properly labeled "aspirational." I once tried to follow her instructions for coloring cloth with natural vegetable dyes. Two hours later, I ended up with blotchy fabric and hands stained by beet juice. I tried, I failed, and I had a funny story to tell. I was intrigued by her demonstration on how to roll an ironed tablecloth in parchment paper to prevent wrinkles. And how nice that she could whip up 80 perfectly iced little cakes in no time. I can't do a single backflip. Must I resent Simone Biles for executing a triple-double in one move? It took Superwoman strength to plant an orchard with 122 trees and who knows how many rose bushes. One interviewer noted that people living in Detroit or New York City couldn't do rose gardens. She responded, "But yes, they want roses." The fantasy was more than half the point. Women were among her leading inquisitors. One called her "the most intimidating homemaker on earth." Another female interviewer tells her, "Either they worship you or they say you make us crazy." There was a third possibility — that they found her entertaining. Stewart can lay claim to two heroic feats: She played a big part in improving the quality of American homelife. And she rebuilt a business that had been left for dead. Above all, Martha was a great tough broad. You saw how TV's Larry King kept badgering her about her failed marriage in a way that would have seemed bizarre had the executive been a man. "I had sacrificed a marriage because of the allure of a great job," she finally relented. And she didn't regret it? She did not. I like Stewart, still going strong at 83. More than ever. Harrop, who lives in New York City and Providence, Rhode Island, writes for Creators Syndicate: fharrop@gmail.com . Get local news delivered to your inbox!After almost six years, Devendra Fadnavis set to return to winter assembly as CM
UYO – The Nigerian Army says it has made significant contributions to reduction in oil theft, production output and national economic recovery efforts of the present administration due to its ongoing anti-bunkering operations in the Niger Delta region. Commander 2 Brigade of the Nigerian Army, Brig-Gen Jafaar Ibrahim made the disclosure at the Brigade’s combined West African Social Activities (WASA) held at the Military Cantonment,Mbiokporo, in Nsit-Ibom Local Government Area of Akwa A’Ibom State at the weekend. Ibrahim said the various operations of the Brigade has reduced security threats in the state to the barest minimum and rekindled confidence among residents of the state. He pledged commitment of the Brigade to make Akwa Ibom peaceful in collaboration with other security agencies, adding that all it operations including “Operation Delta Safe Joint Task Force South South (Sector 4), and “Operation Thunder” have significantly reduced activities of criminal elements in the state. In his words “The continuous conduct of various operations in the Brigade’s area of responsibility has drastically decreased security threats and rekindle confidence in Akwa-Ibomites. ” The Brigade will continue to enthusiastically discharge her constitutional responsibility with every form of responsiveness and loyalty. Additionally, the commitment of the Brigade in synergy with other security agencies to make Akwa Ibom State peaceful for law abiding citizen remains unwavering. Operation Delta Safe Joint Task Force South South (Sector 4) and Operation Thunder have drastically degraded the activities of criminal elements within the state. “The Anti-bunkering operation is also curbing oil theft to the barest minimum in the state and boosting national oil production to optimum level for improved national recovery”. Special Guest of honour, Ambassador (Gen.) Godwin Umo (rtd), in his remarks lauded the 2 Brigade for hosting the event and explained that WASA is an agelong tradition inherited from the founding fathers of the Nigerian Army, adding that the initiative was borne out of the need to socialize and celebrate the successes recorded at a particular period. Umo noted that the military profession is full of challenges and stress, adding that WASA and other social activities are designed and organized to de-emphasize such stress and tension, to enable troops confront potential challenges with renewed vigor. “By nature, military profession, all over the World, is full of challenges, stress and tension, therefore WASA and other social functions are designed at deemphasizing such stress and tension to enable troops forge ahead and face any challenge with renewed strength” Umo said Highpoint of the event was presentation of gifts and prizes to personnel who distinguished themselves in their various units and formations, as well as cultural displays by various ethnic groups in the country.
ANDOVER, Mass. , Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the appointment of Mr. Gerardo Hernandez as the Company's Chief Financial Officer, effective December 2, 2024 . In this role, Mr. Hernandez joins the TransMedics executive leadership team, succeeding Mr. Stephen Gordon . To enable a smooth transition, Mr. Gordon will remain a non-executive employee of the Company until March 31, 2025 , before serving as a non-employee senior advisor to the Company focusing on national transplant stakeholder engagement until March 31, 2026 . TransMedics also updated its 2024 financial outlook. Dr. Waleed Hassanein , Mr. Gerardo Hernandez and Mr. Stephen Gordon will attend the upcoming Piper Sandler Conference on December 3, 2024 , the TransMedics Investor & Analyst Day on December 10, 2024 , as well as the J.P. Morgan Healthcare Conference in January 2025 . Mr. Hernandez is an accomplished finance leader with over 25 years of experience across the healthcare and consumer packaged goods (CPG) sectors. He most recently served as Vice President Finance, Head of Corporate Financial Planning and Analysis at Alnylam Pharmaceuticals, a biopharmaceutical company focused on RNAi therapeutics. In this role, Mr. Hernandez led a global team as the company scaled rapidly. Prior to his role at Alnylam, Mr. Hernandez spent nearly a decade at Shire, where he rose through the organization, eventually leading corporate FP&A. During his tenure, Shire was acquired by Takeda in a $62 billion transaction, after which he was instrumental in the integration effort. Mr. Hernandez began his career at Unilever where he held several finance roles of increasing responsibility before joining Shire in 2010. Mr. Hernandez holds a Bachelor of Science degree in Finance from the University of Wisconsin , La Crosse and an MBA in Strategy and Economics from Fundação Getulio Vargas , Sao Paulo, Brazil . "Stephen has been an exceptional partner to me as a member of the TransMedics leadership team for nearly a decade. During his tenure we transitioned the Company from a clinical stage organization to a high growth, publicly traded commercial business," said Waleed Hassanein , M.D., President and Chief Executive Officer. "On behalf of the entire management team and the Board, I want to thank Stephen for his countless contributions to our business that will have lasting benefits for the Company. I am grateful for Stephen's dedication and efforts to advance our corporate strategy while delivering considerable shareholder value, and I look forward to his continued partnership to affect a smooth transition as we start our next chapter at TransMedics." "I am delighted to welcome Gerardo to the TransMedics leadership team as our new Chief Financial Officer," added Dr. Hassanein. "His proven record over two decades of leadership across FP&A functions within high-growth, complex global organizations makes him an ideal addition to our team. I am looking forward to partnering with Gerardo as we continue to deliver significant long-term corporate growth and shareholder value." "I am thrilled to join TransMedics as Chief Financial Officer," said Mr. Hernandez. "I look forward to working with the entire leadership team to expand access to the Company's unparalleled products and services in the organ transplant field while enhancing operational efficiency and delivering lasting value to both our shareholders and the patients we serve." Dr. Hassanein concluded, "As we enter the final weeks of the fourth quarter, we are also updating our financial outlook for the full year 2024. Our updated guidance reflects our continued expectation for considerable year-over-year revenue growth. We look forward to providing additional context at our upcoming Investor & Analyst Day." 2024 Financial Outlook TransMedics now expects revenue for the full year 2024 to be in the range of $428 million to $432 million, which represents 77% to 79% growth compared to the Company's prior year revenue. Piper Sandler 36th Annual Healthcare Conference Members of the TransMedics management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024 , at 4:00 p.m. Eastern Time . A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . The Company's standard investor presentation is also available through this link. TransMedics Investor & Analyst Day Details TransMedics will discuss the transition and updated financial outlook, as well as the Company's growth strategy, clinical pipeline, and operations, in greater detail at its Investor & Analyst Day in New York City on Tuesday, December 10, 2024 , at 10:00 a.m. Eastern Time . A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . Please note management will only take questions from the live audience during the question-and-answer session following formal presentations. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Forward-Looking Statements This press release contains forward-looking statements with respect to, among other things, a leadership transition and our full-year guidance. For this purpose, all statements other than statements of historical facts are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "could," "target," "predict," "seek" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Some of the key factors that could cause actual results to differ include: our ability to maintain profitability on a sustained basis; our ability to attract, train and retain key personnel; our existing and any future indebtedness, including our ability to comply with affirmative and negative covenants under our credit agreement to which we will remain subject until maturity; the fluctuation of our financial results from quarter to quarter; our need to raise additional funding and our ability to obtain it on favorable terms, or at all; our ability to use net operating losses and research and development credit carryforwards; our dependence on the success of the Organ Care System or OCS; our ability to expand access to the OCS through our National OCS Program or NOP; our ability to scale our manufacturing and sterilization capabilities to meet increasing demand for our products; the rate and degree of market acceptance of the OCS; our ability to educate patients, surgeons, transplant centers and private and public payors on the benefits offered by the OCS; our ability to improve the OCS platform and develop the next generation of the OCS products; our dependence on a limited number of customers for a significant portion of our revenue; our ability to maintain regulatory approvals or clearances for our OCS products in the United States , the European Union, and other select jurisdictions worldwide; our ability to adequately respond to the Food and Drug Administration or FDA, or other competent authorities, follow-up inquiries in a timely manner; the performance of our third-party suppliers and manufacturers; our use of third parties to transport donor organs and medical personnel for our NOP and our ability to maintain and grow our logistics capabilities to support our NOP and reduce dependence on third party transportation, including by means of attracting, training and retaining pilots, and the acquisition, maintenance or replacement of fixed-wing aircraft for our aviation transportation services or other acquisitions, joint ventures or strategic investments; our ability to maintain Federal Aviation Administration or FAA or other regulatory licenses or approvals for our aircraft transportation services; price increases of the components of our products and maintenance, parts and fuel for our aircraft; the timing or results of post-approval studies and any clinical trials for the OCS; our manufacturing, sales, marketing and clinical support capabilities and strategy; attacks against our information technology infrastructure; the economic, political and other risks associated with our foreign operations; our ability to protect, defend, maintain and enforce our intellectual property rights relating to the OCS and avoid allegations that our products infringe, misappropriate or otherwise violate the intellectual property rights of third parties; the pricing of the OCS, as well as the reimbursement coverage for the OCS in the United States and internationally; regulatory developments in the United States, European Union and other jurisdictions; the extent and success of competing products or procedures that are or may become available; our ability to service our 1.50% convertible senior notes, due 2028; the impact of any product recalls or improper use of our products; our estimates regarding revenues, expenses and needs for additional financing; and other factors that may be described in our filings with the Securities and Exchange Commission (the "SEC"). Additional information will be made available in our annual and quarterly reports and other filings that we make with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 Investors@transmedics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/transmedics-appoints-gerardo-hernandez-as-chief-financial-officer-and-provides-updated-2024-financial-outlook-302320060.html SOURCE TransMedics Group, Inc.
Fushi Technology To Launch AI Agent Industry Vertical Applications, Accelerating Southeast Asia Market Expansion Media Outreach Newswire APACRevitalizing reading requires sustained attentionNFL hits Texans player with news he didn't want to hear ahead of their Week 12 matchup with their divisional rivals the Titans
Multiple cases registered against Imran Khan's wife for her alleged remarks on Saudi ArabiaAP Sports SummaryBrief at 6:49 p.m. EST
AP Business SummaryBrief at 1:35 p.m. ESTSpecial discounts for Hyderabad metro commuters on Rapido ridesUwill Founder & CEO Michael London Named Innovator in HealthcareNone
AP Business SummaryBrief at 1:35 p.m. EST